Ola Blennow

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Livio Pagano, Jon Salmanton‐García, Francesco Marchesi et al. · Journal of Hematology & Oncology · 2021 · 312 citations · Full text

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Peter Bergman, Ola Blennow, Lotta Hansson et al. · EBioMedicine · 2021 · 219 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

Michael Uhlin, H. Wikell, Mikael Sundin et al. · Haematologica · 2013 · 181 citations · Full text

Transplantation, Marrow Transplantation, Autoimmune Disease +15

Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

Ola Blennow, Per Ljungman, E. Sparrelid et al. · Transplant Infectious Disease · 2013 · 133 citations

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study

Mats Remberger, Malin Ackefors, Sofia Berglund et al. · Biology of Blood and Marrow Transplantation · 2011 · 132 citations · Full text